Bain Capital Life Sciences Fund IV, L.P. (CIK 1996979) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-20). Recent activity: Buy KLRA (16.9M shares), Buy KLRA (4.1M shares), Buy KLRA (1.6M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | Insider | Buy | 16.9M | $0 |
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | Insider | Buy | 4.1M | $0 |
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | Insider | Buy | 1.6M | $25.0M |
Source: SEC Form 4 filings · as of 2026-04-20